Advanced Search

 

Study ID Status Title Patient Level Data
204792 Not yet recruiting Determination of UVA Protection Factor (UVAPF) for a cosmetic product
204799 Not yet recruiting Determination of SPF, before and after (40 and 80 minutes) of immersion in water, for a cosmetic product
204800 Terminated Determination of SPF, before and after (40 and 80 minutes) of immersion in water, for a cosmetic product
204833 Completed Integrated analysis to estimate of the duration of protection provided by GSK’s hepatitis A and B vaccine Twinrix™ administered in healthy adults in a 0-1-6 schedule, based on the 20-year follow-up results of studies HAB-028 and HAB-032.
204853 Completed A Microdose Study to Describe the Intravenous Pharmacokinetics of GSK3191607 in Healthy Male Subjects Following Administration of [14C]-GSK3191607
204870 Completed A Clinical Study to Evaluate the Efficacy of an Experimental Mouthwash Formulation
204900 Completed Meta-analysis of data from FCGR PGx evaluations of ofatumumab CLL studies OMB110911, OMB114242, OMB115991 and OMB110913
204901 PGx7644: Meta-analysis of data from SLE patients treated with Benlysta in studies BEL112341, BEL110752/BLISS-52/C1056, and BEL110751/BLISS-76/C1057
204927 PGx7643: Efficacy pharmacogenetic analysis of SLE patients treated with Benlysta in study BEL112341
205024 Completed Skin Acceptability Assessment of 874A in subjects with sensitive skin Under Normal Usage Conditions
205033 Completed A Randomized, Open-Label, Two-Period, Crossover Bioequivalence Study in Healthy Adult Subjects after Single Oral Dosing of a NCH-GSK Acetylcysteine 2% Oral Solution versus a Reference Fluimucil® Acetylcysteine 2% Oral Solution
205034 An open label study to assess the warming sensation, acceptability and local oral tolerability of NCH-GSK Acetylcysteine 2% Oral Solution, given as a single dose in subjects suffering from productive cough due to upper respiratory tract infection
205034 Completed An open label study to assess the warming sensation, acceptability and local oral tolerability of NCH-GSK Acetylcysteine 2% Oral Solution, given as a single dose in subjects suffering from productive cough due to upper respiratory tract infection
205045 Completed A clinical study investigating the Gingivitis Efficacy of a Stannous Fluoride Dentifrice
205051 Completed A Study to Investigate the Antimicrobial Activity of two Test Toothpastes in a Plaque Glycolysis and Regrowth Model
205064 Completed PGx7648: Exploratory PGx analysis of ADRB2 Thr164Ile on risk of severe asthma exacerbation in study 201722
205072 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205084 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205086 Completed Adelphi disease specific program survey: Satisfaction with current treatment in US systemic lupus erythematous patients
205162 PGX7646: Evaluation of relationships between UGT1A1 and UGT1A9 genotypes and cabotegravir pharmacokinetics and tolerability
205194 Adapt and Perform: the Impact of Increased Dietary Protein on the Metabolic Adaptation to Endurance Running and Subsequent Endurance Performance
205194 Completed Adapt and Perform: the Impact of Increased Dietary Protein on the Metabolic Adaptation to Endurance Running and Subsequent Endurance Performance
205194 Completed Adapt and Perform: the Impact of Increased Dietary Protein on the Metabolic Adaptation to Endurance Running and Subsequent Endurance Performance
205201 Completed Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205212 Completed Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.